How Different Forms of Cellular Level Sequencing is Evolving Under Precision Medicine

Over the years, the study of treatments, medicines, and services that collectively help in providing relief to patients is the study of healthcare. The healthcare industry is vast, and several types of categories are covered under it. Each day a new discovery or technological advancements is occurring across the healthcare industry. Analysts at BIS Research, scans and tracks the pulse of healthcare very closely, to provide significant insights to the users.

The entire healthcare industry is categorized into different segments for the purpose of study. These segments include life sciences and biopharma, precision medicine, robotics and imaging, medical technology (MedTech), and digital health.

Among the aforementioned segments, precision medicine in particular is gaining a lot of traction. Where precision medicine is a model according to which medical treatment for each individual is customized to suit the individual’s body.

Some of the most prominent technologies that are covered under precision medicine, include single cell sequencing, RNA sequencing, human microbiome sequencing, companion diagnostics, DNA damage response drugs, and population sequencing, among others. Each and every technological advancement has a market of its own and is studied in-depth to provide various answers pertaining to the chronic diseases and ailments affecting the mankind, today.

The single cell sequencing refers to the study of individual cells and understanding their functions. The study of single cell also helps in reflecting how each and every cell is responsible for affecting overall mark up of the body. The study of single cell sequencing helps in understanding the DNA of body. Also, RNA sequencing is a segment of study covered under the single cell sequencing. Based on the study of BIS Research, the single cell sequencing market is expected to reach $5,985.6 million by the 2029, growing at a CAGR of 15.24% during the forecast period from 2019–2029.

The genomic approach that helps in identification and qualification of RNA molecules in a biological sample is known as RNA sequencing. With the help of RNA sequencing diagnosis of several rare diseases can be conducted. These rare diseases range from mitochondrial diseases to rare muscular disorders. Some of the mitochondrial diseases it can help in diagnosing include Kearns-Sayre syndrome, mitochondrial depletion syndrome, and Leigh’s syndrome. Further, the use of RNA sequencing as a technique can help assess the progression of several rare diseases.

BIS Research offers exclusive market intelligence reports on disruptive technologies. Each year we publish over 200 titles across industry verticals.